Lucid Diagnostics (LUCD) Operating Leases (2022 - 2026)

Lucid Diagnostics has reported Operating Leases for 5 years, with the latest figure at $695000.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 71.86% year-over-year to $695000.0; the trailing twelve-month figure through Mar 2026 stood at $695000.0 (down 71.86% YoY), and the FY2025 full-year result was $1.8 million, down 31.42% from the prior year.
• Operating Leases for Q1 2026 stood at $695000.0, down from $1.8 million in the prior quarter.
• The five-year high for Operating Leases was $3.0 million in Q2 2024, with the low at $177000.0 in Q1 2024.
• Historically, Operating Leases has averaged $1.6 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2024 — Operating Leases sank 90.57% — and 2025, when it soared 1295.48%.
• Lucid Diagnostics' Operating Leases stood at $1.0 million in 2022, then rose by 25.84% to $1.3 million in 2023, then surged by 103.37% to $2.7 million in 2024, then plunged by 31.42% to $1.8 million in 2025, then tumbled by 61.81% to $695000.0 in 2026.
• The last three Operating Leases figures came in at $695000.0 (Q1 2026), $1.8 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.